Symbol Name ID |
Rasal2
RAS protein activator like 2 MGI:2443881 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Rasal2Gt(463C12)Cmhd/Rasal2+ Trp53tm1Tyj/Trp53tm1Tyj involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl |
increased metastatic potential | J:202603 |
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd Tg(MMTVneu)202Mul/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl * FVB/N |
increased mammary adenocarcinoma incidence | J:202603 |
increased metastatic potential | J:202603 | |
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd Trp53tm1Tyj/Trp53tm1Tyj involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl |
decreased tumor-free survival time | J:202603 |
increased colon adenoma incidence | J:202603 | |
increased hepatocellular carcinoma incidence | J:202603 | |
increased liver tumor incidence | J:202603 | |
increased lymphoma incidence | J:202603 | |
increased metastatic potential | J:202603 | |
increased mouth tumor incidence | J:202603 | |
increased stomach tumor incidence | J:202603 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|